News & Updates

Show Multimedia Only

Abbreviated DAPT found safe in high-risk patients undergoing PCI

22 Jul 2026

In patients at high risk of bleeding who are undergoing percutaneous coronary intervention (PCI), abbreviated dual antiplatelet therapy (DAPT) durations, especially 3-month regimens, reduces bleeding events without increasing the risk of fatal or nonfatal ischaemic cardiovascular or cerebrovascular events when compared with standard DAPT durations, according to a meta-analysis.

Abbreviated DAPT found safe in high-risk patients undergoing PCI

22 Jul 2026

Patients with bipolar II disorder at risk of dying early

22 Jul 2026 by

Bipolar II disorder (BD-II) is associated with an excess risk of premature death from both natural and unnatural causes, according to a retrospective study from Taiwan.

Patients with bipolar II disorder at risk of dying early

22 Jul 2026

Night shift work may impair vascular function in healthy adults

22 Jul 2026

Adults who constantly work the night shift are at greater risk of impaired endothelial function, driven potentially by disrupted sleep and reduced physical activity, reveals a study.

Night shift work may impair vascular function in healthy adults

22 Jul 2026

Resmetirom shows antifibrotic efficacy in MASH via AI-based quantification

22 Jul 2026 by

Treatment with the thyroid hormone beta agonist resmetirom significantly improves qFibrosis continuous values (qFC), categorical stages (qFS), and individual collagen features associated with fibrosis progression at week 52 compared with placebo in patients with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH), as shown in the phase III MAESTRO-NASH trial.

Resmetirom shows antifibrotic efficacy in MASH via AI-based quantification

22 Jul 2026

Older age, obesity, T2D linked to hypertension-mediated organ damage

22 Jul 2026

Factors including older age, obesity, and type 2 diabetes (T2D) characterize individuals with subclinical hypertension-mediated organ damage (HMOD) in The Maastricht Study.

Older age, obesity, T2D linked to hypertension-mediated organ damage

22 Jul 2026

Subclinical cardiac remodeling tied to increased cancer risk

22 Jul 2026 by

A study using data from the MESA* cohort shows an association between subclinical cardiac remodeling and increased risk of cancer.

Subclinical cardiac remodeling tied to increased cancer risk

22 Jul 2026

OS data show promise for risvutatug rezetecan in R/R sarcoma

22 Jul 2026 by

Longer-term follow-up of the phase II ARTEMIS-002 trial continues to show promising efficacy of risvutatug rezetecan (ris-rez) in relapsed or refractory (R/R) sarcoma, with median overall survival (OS) reaching about 2 years, according to data presented at ESMO TAT Asia 2026.

OS data show promise for risvutatug rezetecan in R/R sarcoma

22 Jul 2026

Post-MI beta-blocker use lowers mortality risk in COPD patients

22 Jul 2026

Beta-blocker therapy following myocardial infarction (MI) reduces the risk of death in patients with comorbid chronic obstructive pulmonary disease (COPD), with the magnitude of benefit similar to that observed in patients without COPD, according to a Danish cohort study.

Post-MI beta-blocker use lowers mortality risk in COPD patients

22 Jul 2026

Steroid safety made simple with the new MOH Steroid Card

22 Jul 2026 by

A standardised steroid card is now available after years of effort by a team of endocrinologists and pharmacists from the Ministry of Health (MOH).

Steroid safety made simple with the new MOH Steroid Card

22 Jul 2026

Vedolizumab induces clinical remission in paediatric patients with UC

22 Jul 2026 by

Treatment with either low- or high-dose vedolizumab yields high rates of clinical remission in children with moderate-to-severe ulcerative colitis (UC), regardless of weight, according to the phase III KEPLER trial presented at ESPGHAN 2026.

Vedolizumab induces clinical remission in paediatric patients with UC

22 Jul 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Abbreviated DAPT found safe in high-risk patients undergoing PCI

Abbreviated DAPT found safe in high-risk patients undergoing PCI

Patients with bipolar II disorder at risk of dying early

Patients with bipolar II disorder at risk of dying early

Night shift work may impair vascular function in healthy adults

Night shift work may impair vascular function in healthy adults

Resmetirom shows antifibrotic efficacy in MASH via AI-based quantification

Resmetirom shows antifibrotic efficacy in MASH via AI-based quantification

Older age, obesity, T2D linked to hypertension-mediated organ damage

Older age, obesity, T2D linked to hypertension-mediated organ damage

Subclinical cardiac remodeling tied to increased cancer risk

Subclinical cardiac remodeling tied to increased cancer risk

OS data show promise for risvutatug rezetecan in R/R sarcoma

OS data show promise for risvutatug rezetecan in R/R sarcoma

Post-MI beta-blocker use lowers mortality risk in COPD patients

Post-MI beta-blocker use lowers mortality risk in COPD patients

Steroid safety made simple with the new MOH Steroid Card

Steroid safety made simple with the new MOH Steroid Card

Vedolizumab induces clinical remission in paediatric patients with UC

Vedolizumab induces clinical remission in paediatric patients with UC